{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer's disease", "BACE1", "Cholinesterase", "Isoxazole", "Metal chelating", "Morris water Maze", "Tacrine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34273065", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "02"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "07", "Day": "17"}], "Language": ["eng"], "ELocationID": ["10.1007/s11030-021-10248-w"], "Journal": {"ISSN": "1573-501X", "JournalIssue": {"Volume": "26", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Feb"}}, "Title": "Molecular diversity", "ISOAbbreviation": "Mol Divers"}, "ArticleTitle": "Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer's disease.", "Pagination": {"StartPage": "409", "EndPage": "428", "MedlinePgn": "409-428"}, "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is now ranked as the third leading cause of death after heart disease and cancer. There is no definite cure for AD due to the multi-factorial nature of the disease, hence, multi-target-directed ligands (MTDLs) have attracted lots of attention. In this work, focusing on the efficient cholinesterase inhibitory activity of tacrine, design and synthesis of novel arylisoxazole-tacrine analogues was developed. In vitro acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibition assay confirmed high potency of the title compounds. Among them, compounds 7l and 7b demonstrated high activity toward AChE and BChE with IC<sub>50</sub> values of 0.050 and 0.039\u00a0\u03bcM, respectively. Both compounds showed very good self-induced A\u03b2 aggregation and AChE-induced inhibitory activity (79.4 and 71.4% for compound 7l and 61.8 and 58.6% for compound 7b, respectively). Also, 7l showed good anti-BACE1 activity with IC<sub>50</sub> value of 1.65\u00a0\u00b5M. The metal chelation test indicated the ability of compounds 7l and 7b to chelate biometals (Zn<sup>2+</sup>, Cu<sup>2+</sup>, and Fe<sup>2+</sup>). However, they showed no significant neuroprotectivity against A\u03b2-induced damage in PC12 cells. Evaluation of in vitro hepatotoxicity revealed comparable toxicity of compounds 7l and 7b with tacrine. In vivo studies by Morris water maze (MWM) task demonstrated that compound 7l significantly reversed scopolamine-induced memory deficit in rats. Finally, molecular docking studies of compounds 7l and 7b confirmed establishment of desired interactions with the AChE, BChE, and BACE1 active sites."], "CopyrightInformation": "\u00a9 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Rastegari", "ForeName": "Arezoo", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Iranian Research Organization for Science and Technology (IROST), Tehran, Iran."}], "LastName": "Safavi", "ForeName": "Maliheh", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Vafadarnejad", "ForeName": "Fahimeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran."}], "LastName": "Najafi", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Hariri", "ForeName": "Roshanak", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Aljouf, 2014, Sakaka, Saudi Arabia."}], "LastName": "Bukhari", "ForeName": "Syed Nasir Abbas", "Initials": "SNA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}, {"Identifier": [], "Affiliation": "Central Research laboratory, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Iraji", "ForeName": "Aida", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Edraki", "ForeName": "Najmeh", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Firuzi", "ForeName": "Omidreza", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Saeedi", "ForeName": "Mina", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Mahdavi", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran. akbarzad@tums.ac.ir."}, {"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. akbarzad@tums.ac.ir."}], "LastName": "Akbarzadeh", "ForeName": "Tahmineh", "Initials": "T"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mol Divers", "NlmUniqueID": "9516534", "ISSNLinking": "1381-1991"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid beta-Peptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "4VX7YNB537", "NameOfSubstance": "Tacrine"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "Butyrylcholinesterase"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Amyloid Precursor Protein Secretases"}, {"RegistryNumber": "EC 3.4.23.-", "NameOfSubstance": "Aspartic Acid Endopeptidases"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Amyloid Precursor Protein Secretases"}, {"QualifierName": [], "DescriptorName": "Amyloid beta-Peptides"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Aspartic Acid Endopeptidases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Butyrylcholinesterase"}, {"QualifierName": ["toxicity"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Tacrine"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Patterson C (2018) World Alzheimer Report 2018\u2014The State of the Art of Dementia Research: New Frontiers. Alzheimer\u2019s Disease International (ADI), London"}, {"Citation": "Deture MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 5:1\u201318. https://doi.org/10.1186/s13024-019-0333-5", "ArticleIdList": ["10.1186/s13024-019-0333-5"]}, {"Citation": "https://alz-journals.onlinelibrary.wiley.com/doi/full/ https://doi.org/10.1002/alz.12068"}, {"Citation": "Piton M, Hirtz C, Desmetz C, Milhau J, Dominique-Lajoix A, Bennys K, Lehmann S, Gabelle A (2018) Alzheimer\u2019s disease: advances in drug development. J Alzheimers Dis 65(1):3\u201313. https://doi.org/10.3233/JAD-180145", "ArticleIdList": ["10.3233/JAD-180145", "30040716"]}, {"Citation": "Oxford AE, Stewart ES, Rohn TT (2020) Clinical trials in Alzheimer's disease: A hurdle in the path of remedy. Int J Alzheimers Dis e5380346. https://doi.org/10.1155/2020/5380346 ."}, {"Citation": "Dos-Santos-Picanco LC, Ozela PF, de-Fatima-de-Brito M, Pinheiro AA, Padilha EC, Braga FS, de-Paula-da-Silva CHT, Dos-Santos CBR, Rosa JMC, da-Silva-Hage-Melim LI (2018) Alzheimer's disease: A review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment. Curr Med Chem 25(26):3141-3159. https://doi.org/10.2174/0929867323666161213101126"}, {"Citation": "Tobor TO (2019) On the etiopathogenesis and pathophysiology of Alzheimer\u2019s disease: a comprehensive theoretical review. J Alzheimer\u2019s Dis 68(2):417\u2013437. https://doi.org/10.3233/JAD-181052", "ArticleIdList": ["10.3233/JAD-181052"]}, {"Citation": "Teipel SJ, Fritz HC, Grothe MJ (2020) Alzheimer's disease neuroimaging initiative. Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease. Neurology 95(10):1301\u20131311. https://doi.org/10.1212/WNL.0000000000010192 ."}, {"Citation": "Colautti J, Nagales K (2020) Tau and beta-amyloid in Alzheimer\u2019s disease: Theories, treatments strategies, and future directions. Meducator 1(37):12\u201315. https://doi.org/10.15173/m.v1i37.2502"}, {"Citation": "Castellani RJ, Plascencia-Villa G, Perry G (2019) The amyloid cascade and Alzheimer\u2019s disease therapeutics: theory versus observation. Lab Invest 99:958\u2013970. https://doi.org/10.1038/s41374-019-0231-z", "ArticleIdList": ["10.1038/s41374-019-0231-z", "30760863"]}, {"Citation": "Moussa-Pacha NM, Abdin SM, Omar HA, Alniss H, Al-Tel TH (2020) BACE1 inhibitors: current status and future directions in treating Alzheimer\u2019s disease. Med Res Rev 40:339\u2013384. https://doi.org/10.1002/med.21622", "ArticleIdList": ["10.1002/med.21622", "31347728"]}, {"Citation": "Bruni AC, Bernardi L, Gabelli C (2020) From beta amyloid to altered proteostasis in Alzheimer\u2019s disease. Ageing Res Rev. https://doi.org/10.1016/j.arr.2020.101126", "ArticleIdList": ["10.1016/j.arr.2020.101126", "32683041"]}, {"Citation": "Cacabelos R (2020) Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer\u2019s disease. Expert Opin Drug Metab Toxicol 16(8):673\u2013701. https://doi.org/10.1080/17425255.2020.1779700", "ArticleIdList": ["10.1080/17425255.2020.1779700", "32520597"]}, {"Citation": "Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR (1982) Alzheimer\u2019s disease and senile dementia: loss of neurons in the basal forebrain. Science 215(4537):1237\u20131239. https://doi.org/10.1126/science.7058341", "ArticleIdList": ["10.1126/science.7058341", "7058341"]}, {"Citation": "Agatonovic-Kustrin S, Kettle C, Morton DW (2018) A molecular approach in drug development for Alzheimer\u2019s disease. Biomed Pharmacother 106:553\u2013565. https://doi.org/10.1016/j.biopha.2018.06.147", "ArticleIdList": ["10.1016/j.biopha.2018.06.147", "29990843"]}, {"Citation": "Sharma K (2019) Cholinesterase inhibitors as Alzheimer\u2019s therapeutics (Review). Mol Med Rep 20(2):1479\u20131487. https://doi.org/10.3892/mmr.2019.10374", "ArticleIdList": ["10.3892/mmr.2019.10374", "31257471", "6625431"]}, {"Citation": "Kabir MT, Uddin MS, Begum MM, Thangapandiyan S, Rahman MS, Aleya L, Mathew B, Ahmed M, Barreto GE, Ashraf GM (2019) Cholinesterase inhibitors for Alzheimer\u2019s disease: multitargeting strategy based on anti-Alzheimer\u2019s drugs repositioning. Curr Pharm Des 25(33):3519\u20133535. https://doi.org/10.2174/1381612825666191008103141", "ArticleIdList": ["10.2174/1381612825666191008103141", "31593530"]}, {"Citation": "Martinez A, Castro A (2006) Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer\u2019s disease. Expert Opin Invest Drugs 15(1):1\u201312. https://doi.org/10.1517/13543784.15.1.1", "ArticleIdList": ["10.1517/13543784.15.1.1"]}, {"Citation": "Ismaili L, Refouvelet B, Benchekroun M, Brogi S, Brindisi M, Gemma S, Campiani G, Filipic S, Agbaba D, Esteban G, Unzeta M, Nikolic K, Butini S, Marco-Contelles J (2017) Multitarget compounds bearing tacrine-and donepezil-like structural and functional motifs for the potential treatment of Alzheimer\u2019s disease. Prog Neurobiol 151:4\u201334. https://doi.org/10.1016/j.pneurobio.2015.12.003", "ArticleIdList": ["10.1016/j.pneurobio.2015.12.003", "26797191"]}, {"Citation": "McEneny-King A, Osman W, Edginton AN, Rao PPN (2017) Cytochrome P450 binding studies of novel tacrine derivatives: predicting the risk of hepatotoxicity. Bioorg Med Chem Lett 27(11):2443\u20132449. https://doi.org/10.1016/j.bmcl.2017.04.006", "ArticleIdList": ["10.1016/j.bmcl.2017.04.006", "28400237"]}, {"Citation": "Sameem B, Saeedi M, Mahdavi M, Shafiee A (2017) A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer\u2019s disease. Eur J Med Chem 128:332\u2013345. https://doi.org/10.1016/j.ejmech.2016.10.060", "ArticleIdList": ["10.1016/j.ejmech.2016.10.060", "27876467"]}, {"Citation": "Riazimontazer E, Sadeghpour H, Nadri H, Sakhteman A, T\u00fcyl\u00fc K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7 T, Miri R, Edraki N (2019) Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives. Bioorg Chem 89:103006. https://doi.org/10.1016/j.bioorg.2019.103006", "ArticleIdList": ["10.1016/j.bioorg.2019.103006", "31158577"]}, {"Citation": "Makhaeva GF, Kovaleva NV, Boltneva NP, Lushchekina SV, Rudakova EV, Stupina TS, Terentiev AA, Serkov IV, Proshin AN, Radchenko EV, Palyulin VA, Bachurin SO, Richardson RJ (2020) Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer\u2019s disease treatment: synthesis, quantum-chemical characterization, molecular docking, and biological evaluation. Bioorg Chem 94:103387. https://doi.org/10.1016/j.bioorg.2019.103387", "ArticleIdList": ["10.1016/j.bioorg.2019.103387", "31735356"]}, {"Citation": "Korabecny J, Musilek K, Zemek F, Horova A, Holas O, Nepovimova E, Opletalova V, Hroudova J, Fisar Z, Jung YS, Kuca K (2011) Synthesis and in vitro evaluation of 7-methoxy-N-(pent-4-enyl)-1,2,3,4-tetrahydroacridin-9-amine-new tacrine derivate with cholinergic properties. Bioorg Med Chem Lett 21:6563\u20136566. https://doi.org/10.1016/j.bmcl.2011.08.042", "ArticleIdList": ["10.1016/j.bmcl.2011.08.042", "21920739"]}, {"Citation": "Pan T, Xie S, Zhou Y, Hu J, Luo H, Li X, Huang L (2019) Dual functional cholinesterase and PDE4D inhibitors for the treatment of Alzheimer\u2019s disease: design, synthesis and evaluation of tacrine-pyrazolo[3,4-b]pyridine hybrids. Bioorg Med Chem Lett 29(16):2150\u20132152. https://doi.org/10.1016/j.bmcl.2019.06.056", "ArticleIdList": ["10.1016/j.bmcl.2019.06.056", "31281020"]}, {"Citation": "Najafi Z, Mahdavi M, Mahdavi M, Saeedi M, Karimpour-Razkenari E, Asatouri R, Vafadarnejad F, Homayouni-Moghadam F, Khanavi M, Sharifzadeh M, Akbarzadeh T (2017) Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors. Eur J Med Chem 125:1200\u20131212. https://doi.org/10.1016/j.ejmech.2016.11.008", "ArticleIdList": ["10.1016/j.ejmech.2016.11.008", "27863370"]}, {"Citation": "Hu MK, Lu CF (2000) A facile synthesis of bis-tacrine isosteres. Tetrahedron Lett 41(11):1815\u20131818. https://doi.org/10.1016/S0040-4039(00)00036-8", "ArticleIdList": ["10.1016/S0040-4039(00)00036-8"]}, {"Citation": "Najafi Z, Mahdavi M, Saeedi M, Karimpour-Razkenari E, Edraki N, Sharifzadeh M, Khanavi M, Akbarzadeh T (2019) Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer\u2019s compounds: In vitro and in vivo biological evaluation and docking study. Bioorg Chem 83:303\u2013316. https://doi.org/10.1016/j.bioorg.2018.10.056", "ArticleIdList": ["10.1016/j.bioorg.2018.10.056", "30396115"]}, {"Citation": "Saeedi M, Rastegari A, Hariri R, Mirfazli SS, Mahdavi M, Edraki N, Firuzi O, Akbarzadeh T (2020) Design and synthesis of novel arylisoxazole-chromenone carboxamides: investigation of biological activities associated with Alzheimer\u2019s disease. Chem Biodivers 17(5):e1900746. https://doi.org/10.1002/cbdv.201900746", "ArticleIdList": ["10.1002/cbdv.201900746", "32154628"]}, {"Citation": "Vafadarnejad F, Mahdavi M, Karimpour-Razkenari E, Edraki N, Sameem B, Khanavi M, Saeedi M, Akbarzadeh T (2018) Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity. Bioorg Chem 77:311\u2013319. https://doi.org/10.1016/j.bioorg.2018.01.013", "ArticleIdList": ["10.1016/j.bioorg.2018.01.013", "29421707"]}, {"Citation": "Najafi Z, Mahdavi M, Saeedi M, Sabourian R, Khanavi M, Safavi M, Tehrani MB, Shafiee A, Foroumadi A, Akbarzadeh T (2017) 1,2,3-Triazole-Isoxazole based acetylcholinesterase inhibitors: synthesis, biological evaluation and docking Study. Lett Drug Des Discov 14:58\u201365. https://doi.org/10.2174/1570180813666160628085515", "ArticleIdList": ["10.2174/1570180813666160628085515"]}, {"Citation": "Saeedi M, Safavi M, Allahabadi E, Rastegari A, Hariri R, Jafari S, Bukhari SNA, Mirfazli SS, Firuzi O, Edraki N, Mahdavi M, Akbarzadeh T (2020) Thieno[2,3-b]pyridine amines: synthesis and evaluation of tacrine analogs against biological activities related to Alzheimer\u2019s disease. Arch Pharm 353:e2000101. https://doi.org/10.1002/ardp.202000101", "ArticleIdList": ["10.1002/ardp.202000101"]}, {"Citation": "Karimi-Askarani H, Iraji A, Rastegari A, Abbas-Bukhari SN, Firuzi O, Akbarzadeh T, Saeedi M (2020) Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease. BMC Chem 14(1):pe64. https://doi.org/10.1186/s13065-020-00715-0 ."}, {"Citation": "Iraji A, Firuzi O, Khoshneviszadeh M, Tavakkoli M, Mahdavi M, Nadri H, Edraki N, Miri R (2017) Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer\u2019s disease. Eur J Med Chem 141:690\u2013702. https://doi.org/10.1016/j.ejmech.2017.09.057", "ArticleIdList": ["10.1016/j.ejmech.2017.09.057", "29107423"]}, {"Citation": "Iraji A, Firuzi O, Khoshneviszadeh M, Nadri H, Edraki N, Miri R (2018) Synthesis and structure-activity relationship study of multi-target triazine derivatives as innovative candidates for treatment of Alzheimer\u2019s disease. Bioorg Chem 77:223\u2013235. https://doi.org/10.1016/j.bioorg.2018.01.017", "ArticleIdList": ["10.1016/j.bioorg.2018.01.017", "29367079"]}, {"Citation": "Edraki N, Firuzi O, Fatahi Y, Mahdavi M, Asadi M, Emami S, Divsalar K, Miri R, Iraji A, Khoshneviszadeh M, Firoozpour L, Shafiee A, Foroumadi A (2015) N-(2-(Piperazin-1-yl)phenyl)arylamide derivatives as \u03b2-secretase (BACE1) inhibitors: simple synthesis by Ugi Four-component reaction and biological evaluation. Arch Pharm 348(5):330\u2013337. https://doi.org/10.1002/ardp.201400322", "ArticleIdList": ["10.1002/ardp.201400322"]}, {"Citation": "Martorana A, Giacalone V, Bonsignore R, Pace A, Gentile C, Pibiri I, Buscemi S, Lauria A, Piccionello AP (2016) Heterocyclic scaffolds for the treatment of Alzheimer\u2019s disease. Curr Pharm Des 22:3971\u20133995", "ArticleIdList": ["10.2174/1381612822666160518141650"]}, {"Citation": "Saeedi M, Mohtadi-Haghighi D, Mirfazli SS, Mahdavi M, Hariri R, Lotfian H, Edraki N, Iraji A, Firuzi O, Akbarzadeh T (2019) Design and synthesis of selective acetylcholinesterase inhibitors: Arylisoxazole-Phenylpiperazine derivatives. Chem Biodivers 16:e1800433. https://doi.org/10.1002/cbdv.201800433", "ArticleIdList": ["10.1002/cbdv.201800433", "30460743"]}, {"Citation": "Vafadarnejad F, Saeedi M, Mahdavi M, Rafinejad A, Karimpour-Razkenari E, Sameem B, Khanavi M, Akbarzadeh T (2017) Novel indole-isoxazole hybrids: synthesis and in vitro anti-cholinesterase activity. Lett Drug Des Discov 14:712\u2013717. https://doi.org/10.2174/1570180813666161018124726", "ArticleIdList": ["10.2174/1570180813666161018124726"]}, {"Citation": "Vafadarnejad F, Karimpour-Razkenari E, Sameem B, Saeedi M, Firuzi O, Edraki N, Mahdavi M, Akbarzadeh T (2019) Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study. Bioorg Chem 92:103192. https://doi.org/10.1016/j.bioorg.2019.103192", "ArticleIdList": ["10.1016/j.bioorg.2019.103192", "31446239"]}, {"Citation": "Ragab HM, Teleb M, Haidar HR, Gouda N (2019) Chlorinated tacrine analogs: Design, synthesis and biological evaluation of their anti-cholinesterase activity as potential treatment for Alzheimer\u2019s disease. Bioorg Chem 86:557\u2013568. https://doi.org/10.1016/j.bioorg.2019.02.033", "ArticleIdList": ["10.1016/j.bioorg.2019.02.033", "30782574"]}, {"Citation": "Ragab HM, Ashour HMA, Galal A, Ghoneim AI, Haidar HR (2016) Synthesis and biological evaluation of some tacrine analogs: study of the effect of the chloro substituent on the acetylcholinesterase inhibitory activity. Monatsh Chem 147:539\u2013552. https://doi.org/10.1007/s00706-015-1641-2", "ArticleIdList": ["10.1007/s00706-015-1641-2"]}, {"Citation": "Keri RS, Quintanova C, Chaves S, Silva DF, Cardoso SM, Santos MA (2016) New tacrine hybrids with natural-based cysteine derivatives as multitargeted drugs for potential treatment of Alzheimer\u2019s disease. Chem Biol Drug Des 87(1):101\u2013111. https://doi.org/10.1111/cbdd.12633", "ArticleIdList": ["10.1111/cbdd.12633", "26256122"]}, {"Citation": "Wilcken R, Zimmermann MO, Lange A, Joerger AC, Boeckler FM (2013) Principles and applications of halogen bonding in medicinal chemistry and chemical biology. J Med Chem 56(4):1363\u20131388. https://doi.org/10.1021/jm3012068", "ArticleIdList": ["10.1021/jm3012068", "23145854"]}, {"Citation": "Iraji A, Khoshneviszadeh M, Firuzi O, Khoshneviszadeh M, Edraki N (2020) Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands. Bioorg Chem 97:e103649. https://doi.org/10.1016/j.bioorg.2020.103649", "ArticleIdList": ["10.1016/j.bioorg.2020.103649"]}, {"Citation": "Yazdani M, Edraki N, Badri R, Khoshneviszadeh M, Iraji A, Firuzi O (2020) 5,6-Diphenyl triazine-thio methyl triazole hybrid as a new Alzheimer\u2019s disease modifying agents. Mol Divers 24:641\u2013654. https://doi.org/10.1007/s11030-019-09970-3", "ArticleIdList": ["10.1007/s11030-019-09970-3", "31327094"]}, {"Citation": "Liao J, Nai Y, Feng L, Chen Y, Li M, Xu H (2020) Walnut oil prevents scopolamine-induced memory dysfunction in a mouse model. Molecules 25:pe1630. https://doi.org/10.3390/molecules25071630 ."}, {"Citation": "Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1:848\u2013858. https://doi.org/10.1038/nprot.2006.116", "ArticleIdList": ["10.1038/nprot.2006.116", "17406317", "2895266"]}, {"Citation": "Brandeis R, Brandys Y, Yehuda S (1989) The use of the Morris Water Maze in the study of memory and learning. Int J Neurosci 48(1\u20132):29\u201369. https://doi.org/10.3109/00207458909002151", "ArticleIdList": ["10.3109/00207458909002151", "2684886"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "4", "Day": "3"}, {"Year": "2021", "Month": "6", "Day": "5"}, {"Year": "2021", "Month": "7", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "17", "Hour": "12", "Minute": "9"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34273065", "10.1007/s11030-021-10248-w", "10.1007/s11030-021-10248-w"]}}], "PubmedBookArticle": []}